Matinas Biopharma (MTNB) Q2 2024 Earnings

9MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.03
0.3
0.64
0.97

Details

Expected EPS
-0.03
Actual EPS
-0.03
Surprise EPS
0
Surprise Percent
+0%

Description

Matinas Biopharma (MTNB) has reported earnings of -0.03 per share for Q2 2024.

0 Comments

Share your thoughts